Innovation, Research
Ribonexus: Overcoming resistance to cancer treatments
… behind Ribonexus, a start-up created by the Institut Curie and Institut Gustave Roussy last November. Today, there are … increase life expectancy for patients: immunotherapy and targeted therapy, both of which were put on the market … compared to host cells. For Caroline Robert, “their strategy is complex because not all mRNAs are controlled in …Published on: